A structurally conserved water molecule in Rossmann dinucleotide-binding domains

Protein Science

Volumn 11, Issue 9, 2002, Pages 2125-2137

  Bottoms, Christopher A ^a   Smith, Paul E ^b   Tanner, John J ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

Dinucleotide protein interactions; FAD; Molecular recognition; NAD; NADP; Rossmann fold; Structurally conserved water molecule

Indexed keywords

APOENZYME; DINUCLEOTIDE; ENZYME; FLAVINE ADENINE NUCLEOTIDE; GLYCINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PHOSPHATE; PYROPHOSPHATE; SOLVENT; WATER; BACTERIAL PROTEIN; FUNGAL PROTEIN; PROTOZOAL PROTEIN; VEGETABLE PROTEIN;

ARTICLE; BETA SHEET; BINDING SITE; CALCULATION; CARBOXY TERMINAL SEQUENCE; HYDROGEN BOND; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; PROTEIN BINDING; PROTEIN CONFORMATION;

ANIMAL; BACTERIAL PROTEINS; BINDING SITES; FLAVIN-ADENINE DINUCLEOTIDE; FUNGAL PROTEINS; GLYCINE; HUMAN; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NAD; NADP; PLANT PROTEINS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTOZOAN PROTEINS; SOLVENTS; SUPPORT, NON-U.S. GOV'T; WATER; ANIMALS; HUMANS;

EID: 0036707995     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.0213502     Document Type: Article

References (120)

1. Structural basis for substrate specificity differences of horse liver alcohol dehydrogenase isozymes
2. Refined crystal structure of liver alcohol dehydrogenase-NADH complex at 1.8 Å resolution
3. The 3-D structure of a folate-dependent dehydrogenase/cyclohydrolase bifunctional enzyme at 1.5 Å resolution
4. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design
5. The 1.25 Å crystal structure of sepiapterin reductase reveals its binding mode to pterins and brain neurotransmitters
6. Sequestration of the active site by interdomain shifting. Crystallographic and spectroscopic evidence for distinct conformations of L-3-hydroxyacyl-CoA dehydrogenase
7. Enzyme inactivation through sulfhydryl oxidation by physiologic NO-carriers
8. The protein data bank
9. Crystal structure of the catalytic core component of the alkylhydroperoxide reductase AhpF from Escherichia coli
10. Structural bases for inhibitor binding and catalysis in polyamine oxidase
11. A 30 Å long U-shaped catalytic tunnel in the crystal structure of polyamine oxidase
12. The crystal structure of plant acetohydroxy acid isomeroreductase complexed with NADPH, two magnesium ions and a herbicidal transition state analog determined at 1.65 Å resolution
13. Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 Å resolution. I. General features and binding of methotrexate
14. Chapter 10: Enzymes that bind nucleotides
15. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design
16. Crystallography & NMR system: A new software suite for macromolecular structure determination
17. Rhodococcus L-phenylalanine dehydrogenase: Kinetics, mechanism, and structural basis for catalytic specificity
18. Structure of dehydroquinate synthase reveals an active site capable of multistep catalysis
19. NADP-dependent enzymes. I: Conserved stereochemistry of cofactor binding
20. The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 Å resolution
21. Flexibility of liver alcohol dehydrogenase in stereoselective binding of 3-butylthiolane 1-oxides
22. New insights for dinucleotide backbone binding in conserved C5′-H...O hydrogen bonds
23. +
24. + and 2-oxoisocaproate at 1.9 Å resolution
25. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis
26. Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil
27. Comparison of the structures of wild-type and a N313T mutant of Escherichia coli glyceraldehyde 3-phosphate dehydrogenases: Implication for NAD binding and cooperativity
28. The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for antimalarial design
29. Organization of the multiple coenzymes and subunits and role of the covalent flavin link in the complex heterotetrameric sarcosine oxidase
30. Structures of recombinant human and mouse NAD(P)H: Quinone oxidoreductases: Species comparison and structural changes with substrate binding and release
31. Structure-based development of anticancer drugs: Complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones
32. Isosteric analogues of nicotinamide adenine dinucleotide derived from furanfurin, thiophenfurin, and selenophenfurin as mammalian inosine monophosphate dehydrogenase (type I and II) inhibitors
33. Refined crystal structure of mitochondrial malate dehydrogenase from porcine heart and the consensus structure for dicarboxylic acid oxidoreductases
34. Pteridine reductase mechanism correlates pterin metabolism with drug resistance in trypanosomatid parasites
35. Crystal structure of a ternary complex of Escherichia coli malate dehydrogenase citrate and NAD at 1.9 Å resolution
36. Probing catalysis by Escherichia coli dTDP-glucose-4,6-dehydratase: Identification and preliminary characterization of functional amino acid residues at the active site
37. + binary complex from Agaricus bisporus
38. Wet and dry interfaces: The role of solvent in protein-protein and protein-DNA recognition
39. Improved methods for building protein models in electron density maps and the location of errors in these models
40. Refined structure of glutathione reductase at 1.54 Å resolution
41. Substrate binding and catalysis by glutathione reductase as derived from refined enzyme: Substrate crystal structures at 2 Å resolution
42. Determinants of protein thermostability observed in the 1.9-Å crystal structure of malate dehydrogenase from the thermophilic bacterium Thermus flavus
43. Expression of human IMP dehydrogenase types I and II in Escherichia coli and distribution in human normal lymphocytes and leukemic cell lines
44. NADP-dependent bacterial alcohol dehydrogenases: Crystal structure, cofactor-binding and cofactor specificity of the ADHs of Clostridium beijerinckii and Thermoanaerobacter brockii
45. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
46. High resolution structures of holo and apo formate dehydrogenase
47. Crystal structure of the MJ0490 gene product of the hyperthermophilic archaebacterium Methanococcus jannaschii, a novel member of the lactate/malate family of dehydrogenases
48. NAD-binding domains of dehydrogenases
49. Crystal structure of cholesterol oxidase complexed with a steroid substrate: Implications for flavin adenine dinucleotide dependent alcohol oxidases
50. Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs
51. A structural account of substrate and inhibitor specificity differences between two naphthol reductases
52. A "structural" water molecule in the family of fatty acid binding proteins
53. Amino acid-base interactions: A three-dimensional analysis of protein-DNA interactions at an atomic level
54. Structure-based drug design: Computational advances
55. Structure of L-aspartate oxidase: Implications for the succinate dehydrogenase/fumarate reductase oxidoreductase family
56. Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim
57. On the enzymatic activation of NADH
58. Raster3D photorealistic molecular graphics
59. Structure of glutathione reductase from Escherichia coil at 1.86 Å resolution: Comparison with the enzyme from human erythrocytes
60. Crystal structure of SQD1, an enzyme involved in the biosynthesis of the plant sulfolipid headgroup donor UDP-sulfoquinovose
61. SCOP: A structural classification of proteins database for the investigation of sequences and structures
62. Selective up-regulation of type II inosine 5′-monophosphate dehydrogenase messenger RNA expression in human leukemias
63. Analysis of interaction between the Arthrobacter sarcosine oxidase and the coenzyme flavin adenine dinucleotide by site-directed mutagenesis
64. + and inhibitor mercaptoethanol at 1.7 Å resolution for understanding of chiral substrate recognition mechanisms
65. NADH interactions with WT- and S94A-acyl carrier protein reductase from Mycobacterium tuberculosis: An ab initio study
66. Structure of human biliverdin IXβ reductase, an early fetal bilirubin IXβ producing enzyme
67. Hydration in drug design. 3. Conserved water molecules at the ligand-binding sites of homologous proteins
68. Recognition of structurally diverse substrates by type II 3-hydroxyacyl-CoA dehydrogenase (HADH II)/amyloid-beta binding alcohol dehydrogenase (ABAD)
69. Crystal structure of transhydrogenase domain III at 1.2 Å resolution
70. Common themes in redox chemistry emerge from the X-ray structure of oilseed rape (Brassica napus) enoyl acyl carrier protein reductase
71. Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm
72. Structure of the NADPH-binding motif of glutathione reductase: Efficiency determined by evolution
73. Probing the catalytic mechanism of GDP-4-keto-6-deoxy-d-mannose Epimerase/Reductase by kinetic and crystallographic characterization of site-specific mutants
74. Chemical and biological evolution of a nucleotide-binding protein
75. Crystallographic analysis of triclosan bound to enoyl reductase
76. Insights into ligand binding and catalysis of a central step in NAD+ synthesis: Structures of Methanobacterium thermoautotrophicum NMN adenylyltransferase complexes
77. Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: Crystallographic evidence
78. Strength of the CαH..O hydrogen bond of amino acid residues
79. Crystal structure of the p-hydroxybenzoate hydroxylase-substrate complex refined at 1.9 A resolution. Analysis of the enzyme-substrate and enzyme-product complexes
80. Chirality errors in nucleic acid structures
81. Structure of holo-glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus at 1.8 Å resolution
82. + in solution
83. +) in various environments
84. Buried water in homologous serine proteases
85. Structural basis and mechanism of enoyl reductase inhibition by triclosan
86. Overexpression of Crithidia fasciculata trypanothione reductase and crystallization using a novel geometry
87. Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8 Å resolution: The structural origin of coenzyme specificity in the short-chain dehydrogenase/reductase family
88. Crystal structures of the binary and ternary complexes of 7α-hydroxysteroid dehydrogenase from Escherichia coli
89. Structural and mechanistic mapping of a unique fumarate reductase
90. Crystal structures of the oxidized and reduced forms of UDP-galactose 4-epimerase isolated from Escherichia coli
91. High-resolution X-ray structure of UDP-galactose 4-epimerase complexed with UDP-phenol
92. Molecular structure of the NADH/UDP-glucose abortive complex of UDP-galactose 4-epimerase from Escherichia coli: Implications for the catalytic mechanism
93. Structural analysis of UDP-sugar binding to UDP-galactose 4-epimerase from Escherichia coli
94. Crystallographic evidence for Tyr 157 functioning as the active site base in human UDP-galactose 4-epimerase
95. Human UDP-galactose 4-epimerase. Accomodation of UDP-N-acetylglcosamine within the active site
96. The X-ray structure of D-amino acid oxidase at very high resolution identifies the chemical mechanism of flavin-dependent substrate dehydrogenation
97. Synthesis and structure-activity relationships of analogs of 2′-deoxy-2′-(3-methoxybenzamido)adenosine, a selective inhibitor of trypanosomal glycosomal glyceraldehyde-3-phosphate dehydrogenase
98. Peroxisomal D-hydroxyacyI-CoA dehydrogenase deficiency: Resolution of the enzyme defect and its molecular basis in bifunctional protein deficiency
99. Phenylalanine dehydrogenase from Rhodococcus sp. M4: Highresolution X-ray analyses of inhibitory ternary complexes reveal key features in the oxidative deamination mechanism
100. Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: Toward new drugs for the treatment of sleeping sickness
101. Structure-based drug design: Progress, results and challenges
102. Monomeric sarcosine oxidase: 1. Flavin reactivity and active site binding determinants
103. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan
104. + oxidoreductase with and without its substrates bound
105. X-Ray crystal structures of Candida albicans dihydrofolate reductase: High resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor
106. X-ray crystallographic studies of Candida albicans dihydrofolate reductase. High resolution structures of the holoenzyme and an inhibited ternary complex
107. Interaction of pyrophosphate moieties with α-helixes in dinucleotide binding proteins
108. Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches
109. 1.8 and 1.9 Å resolution structures of the Penicillium amagasakiense and Aspergillus niger glucose oxidases as a basis for modelling substrate complexes
110. Crystal structure of glucose dehydrogenase from Bacillus megaterium IWG3 at 1.7 Å resolution
111. + and pseudotropine at 1.9 Å resolution: Implication for stereospecific substrate binding and catalysis
112. Crystal structure determination of cholesterol oxidase from Streptomyces and structural characterization of key active site mutants
113. Nuclear magnetic resonance studies of pyridine dinucleotides.7.1 The solution conformational dynamics of the adenosine portion of nicotinamide adenine dinucleotide and other related purine containing compounds
114. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase
115. Characteristics and crystal structure of bacterial inosine-5′-monophosphate dehydrogenase
116. + and NADPH suggesting a mechanism for the electron transfer of an enzyme family
117. The structure of adrenodoxin reductase of mitochondrial P450 systems: Electron transfer for steroid biosynthesis